• Disease areas
  • Products
  • Sustainable business
  • Partnering & innovation
  • Careers
  • About us
  • Patient help
  • Healthcare professionals
  • Investors
  • News & media
  • Contact us

  • Ozempic® Prescribing Information, including Boxed Warning
  • For Healthcare Professionals
  • For Consumers

  • Rybelsus® Prescribing Information, including Boxed Warning
  • For Healthcare Professionals
  • For Consumers

  • Victoza® Prescribing Information, including Boxed Warning
  • For Healthcare Professionals
  • For Consumers

  • Fiasp® Prescribing Information
  • For Healthcare Professionals
  • For Consumers

  • Novolin® 70/30 Prescribing Information

  • Novolin® N Prescribing Information

  • Novolin® R Prescribing Information

  • NovoLog® Prescribing Information
  • For Healthcare Professionals
  • For Consumers

  • NovoLog® Mix 70/30 Prescribing Information
  • For Healthcare Professionals
  • For Consumers

  • Tresiba® Prescribing Information
  • For Healthcare Professionals
  • For Consumers

  • Xultophy® 100/3.6 Prescribing Information, including Boxed Warning
  • For Healthcare Professionals
  • For Consumers

  • Zegalogue® Prescribing Information
  • For Healthcare Professionals
  • For Consumers

  • GlucaGen® HypoKit® Prescribing Information

  • Levemir® Prescribing Information
Blood glucose monitoring

© 2025 Novo Nordisk All rights reserved. US25DI00070 June 2025

NOVO NORDISK USA

800 Scudders Mill Road
Plainsboro, NJ 08536
Tel: 1-609-987-5800

 

Transparency in Employee Health Coverage:

Aetna
United Healthcare

Helpful links

Contact us Copyright Report a side effect or product complaint

Follow us

Facebook X (Twitter) Instagram

Other offices

Select location
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Privacy Policy
Consumer Health Data Privacy Notice
Cookie Policy
Privacy Request

change